HUP0401312A2 - Peptid-arginálok és ilyen vegyületeket tartalmazó gyógyászati készítmények - Google Patents
Peptid-arginálok és ilyen vegyületeket tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP0401312A2 HUP0401312A2 HU0401312A HUP0401312A HUP0401312A2 HU P0401312 A2 HUP0401312 A2 HU P0401312A2 HU 0401312 A HU0401312 A HU 0401312A HU P0401312 A HUP0401312 A HU P0401312A HU P0401312 A2 HUP0401312 A2 HU P0401312A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- compounds
- general formula
- arginals
- peptide
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 abstract 1
- IADUEWIQBXOCDZ-VKHMYHEASA-N (S)-azetidine-2-carboxylic acid Chemical group OC(=O)[C@@H]1CCN1 IADUEWIQBXOCDZ-VKHMYHEASA-N 0.000 abstract 1
- -1 1-adamantylmethyl group Chemical group 0.000 abstract 1
- 108010074860 Factor Xa Proteins 0.000 abstract 1
- 229930182821 L-proline Natural products 0.000 abstract 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 abstract 1
- 108010001014 Plasminogen Activators Proteins 0.000 abstract 1
- 102000001938 Plasminogen Activators Human genes 0.000 abstract 1
- 108090000190 Thrombin Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001735 carboxylic acids Chemical class 0.000 abstract 1
- 125000004981 cycloalkylmethyl group Chemical group 0.000 abstract 1
- 208000009190 disseminated intravascular coagulation Diseases 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 229940012957 plasmin Drugs 0.000 abstract 1
- 229940127126 plasminogen activator Drugs 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 229960002429 proline Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960004072 thrombin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
A találmány (I) általános képletű peptid-arginálokra és azok szervesvagy szervetlen savval képzett savaddíciós sóira - ahol a képletbenXaa (II) általános képletű, a-szubsztituált karbonsavmaradékot jelent,ahol Q jelentése 1-3 szénatomos alkil-oxi-karbonil-aminocsoport,metil-amino-csoport vagy hidroxilcsoport, és R jelentése 7-9szénatomos cikloalkil-metil-csoport, 5-7 szénatomos cikloalkilcsoportvagy 1-adamantilmetil-csoport, és Xbb jelentése L-prolin vagy L-azetidin-2-karbonsav-maradék - és ilyen vegyületeket tartalmazógyógyászati készítményekre vonatkozik. A találmány tárgya továbbá az(I) általános képletű vegyületek alkalmazása disszemináltintravaszkuláris koaguláció kezelésére alkalmas gyógyászatikészítmények előállítására. A találmány szerinti vegyületek gátlóhatást fejtenek ki alvadékba zárt trombinnal, valamint Xa faktorralszemben, és hatékonyan gátolják a plazmint és a plazminogén-aktivátorokat. Ó
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31385001P | 2001-08-21 | 2001-08-21 | |
| US31390101P | 2001-08-21 | 2001-08-21 | |
| PCT/US2002/026564 WO2003016273A2 (en) | 2001-08-21 | 2002-08-21 | Peptide arginals and methods for treating disseminated intravascular coagulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0401312A2 true HUP0401312A2 (hu) | 2005-02-28 |
| HUP0401312A3 HUP0401312A3 (en) | 2010-04-28 |
Family
ID=26979079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401312A HUP0401312A3 (en) | 2001-08-21 | 2002-08-21 | Peptide arginals and pharmaceutical compositions containing such compounds |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20050070480A1 (hu) |
| EP (1) | EP1425009A4 (hu) |
| JP (1) | JP4230908B2 (hu) |
| KR (1) | KR20040062942A (hu) |
| CN (1) | CN1302776C (hu) |
| AU (1) | AU2002331654B2 (hu) |
| BR (1) | BR0212122A (hu) |
| CA (1) | CA2457436A1 (hu) |
| CZ (1) | CZ2004265A3 (hu) |
| HU (1) | HUP0401312A3 (hu) |
| IL (1) | IL160488A0 (hu) |
| MX (1) | MXPA04001534A (hu) |
| NO (1) | NO20040820L (hu) |
| NZ (1) | NZ531315A (hu) |
| PL (1) | PL368464A1 (hu) |
| RU (1) | RU2312856C2 (hu) |
| SK (1) | SK1112004A3 (hu) |
| WO (1) | WO2003016273A2 (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2062909A1 (en) * | 2007-11-21 | 2009-05-27 | SOLVAY (Société Anonyme) | Peptide production and purification process |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU192646B (en) * | 1984-12-21 | 1987-06-29 | Gyogyszerkutato Intezet | Process for preparing new n-alkyl-peptide aldehydes |
| IL99527A (en) * | 1990-09-28 | 1997-08-14 | Lilly Co Eli | Tripeptide antithrombotic agents |
| US5252566A (en) * | 1991-11-12 | 1993-10-12 | Eli Lilly And Company | Antithrombotic agents |
| AU1186295A (en) * | 1993-11-24 | 1995-06-13 | University Of Washington | Blood coagulation retardants and devices |
| ZA951618B (en) * | 1994-03-04 | 1996-08-27 | Lilly Co Eli | Antithrombotic agents |
| US5484772A (en) * | 1994-03-04 | 1996-01-16 | Eli Lilly And Company | Antithrombotic agents |
| JPH09509943A (ja) * | 1994-03-04 | 1997-10-07 | イーライ・リリー・アンド・カンパニー | 抗血栓剤 |
| US5436229A (en) * | 1994-03-04 | 1995-07-25 | Eli Lilly And Company | Bisulfite adducts of arginine aldehydes |
| HU222199B1 (hu) * | 1996-06-05 | 2003-05-28 | Gyógyszerkutató Intézet Kft. | Véralvadásgátló hatású peptid-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények |
-
2002
- 2002-08-21 EP EP02768632A patent/EP1425009A4/en not_active Withdrawn
- 2002-08-21 MX MXPA04001534A patent/MXPA04001534A/es active IP Right Grant
- 2002-08-21 NZ NZ531315A patent/NZ531315A/en not_active IP Right Cessation
- 2002-08-21 RU RU2004108117/04A patent/RU2312856C2/ru not_active IP Right Cessation
- 2002-08-21 BR BR0212122-0A patent/BR0212122A/pt not_active IP Right Cessation
- 2002-08-21 CZ CZ2004265A patent/CZ2004265A3/cs unknown
- 2002-08-21 SK SK111-2004A patent/SK1112004A3/sk unknown
- 2002-08-21 US US10/487,465 patent/US20050070480A1/en not_active Abandoned
- 2002-08-21 JP JP2003521200A patent/JP4230908B2/ja not_active Expired - Fee Related
- 2002-08-21 IL IL16048802A patent/IL160488A0/xx unknown
- 2002-08-21 AU AU2002331654A patent/AU2002331654B2/en not_active Ceased
- 2002-08-21 CN CNB028200314A patent/CN1302776C/zh not_active Expired - Fee Related
- 2002-08-21 HU HU0401312A patent/HUP0401312A3/hu unknown
- 2002-08-21 PL PL02368464A patent/PL368464A1/xx not_active Application Discontinuation
- 2002-08-21 KR KR10-2004-7002553A patent/KR20040062942A/ko not_active Application Discontinuation
- 2002-08-21 CA CA002457436A patent/CA2457436A1/en not_active Abandoned
- 2002-08-21 WO PCT/US2002/026564 patent/WO2003016273A2/en active Application Filing
-
2004
- 2004-02-20 NO NO20040820A patent/NO20040820L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ2004265A3 (cs) | 2004-08-18 |
| WO2003016273A2 (en) | 2003-02-27 |
| RU2312856C2 (ru) | 2007-12-20 |
| HUP0401312A3 (en) | 2010-04-28 |
| NO20040820L (no) | 2004-05-14 |
| US20050070480A1 (en) | 2005-03-31 |
| RU2004108117A (ru) | 2005-04-10 |
| IL160488A0 (en) | 2004-07-25 |
| CN1302776C (zh) | 2007-03-07 |
| WO2003016273A3 (en) | 2003-06-12 |
| KR20040062942A (ko) | 2004-07-09 |
| PL368464A1 (en) | 2005-04-04 |
| NZ531315A (en) | 2005-08-26 |
| JP2005502657A (ja) | 2005-01-27 |
| EP1425009A4 (en) | 2006-10-25 |
| JP4230908B2 (ja) | 2009-02-25 |
| CA2457436A1 (en) | 2003-02-27 |
| EP1425009A2 (en) | 2004-06-09 |
| CN1607949A (zh) | 2005-04-20 |
| MXPA04001534A (es) | 2004-11-22 |
| AU2002331654B2 (en) | 2007-11-08 |
| BR0212122A (pt) | 2004-07-20 |
| SK1112004A3 (en) | 2004-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Al‐Horani et al. | Recent advances on plasmin inhibitors for the treatment of fibrinolysis‐related disorders | |
| GEP20063871B (en) | Inhibitors of factor xa and other serine proteases involved in the coagulation cascade | |
| DE69229151D1 (de) | Pseudopeptide und Dipeptide, die durch eine substituierte Methylketoneinheit am C-Terminus gekennzeichnet sind als Inhibitoren von Thiol-Proteasen | |
| PT923570E (pt) | Amidas de acidos piridil-alcenoicos e piridil-alcinicos como agentes citostaticos e imunossupressivos | |
| HUP0100669A2 (hu) | Szerin proteázokat gátló peptidszármazékok és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
| AR012588A1 (es) | UN INHIBIDOR DE SERINA PROTEASA, UNA COMPOSICIoN FARMACEUTICA QUE LO COMPRENDE Y UN PROCEDIMIENTO PARA PREPARAR UNA COMPOSICIoN FARMACEUTICA | |
| ECSP034922A (es) | Pirrolopirimidinas | |
| BR0210644A (pt) | Composto, formulação farmacêutica, método para inibir uma protease que cliva pós prolina/alanina, método para o tratamento ou profilaxia de distúrbios, e, uso do composto | |
| NO20020217L (no) | Nitrogenholdige heterobisykler som faktor Xa-inhibitorer | |
| MY119155A (en) | New peptide derivatives | |
| YU65804A (sh) | Nova heterociklična jedinjenja aktivna kao inhibitori beta-laktamaze | |
| PT816376E (pt) | Inibidores de trombina como agentes anticoagulantes | |
| BR0011130A (pt) | Inibidores de metaloproteases | |
| HUP0100723A2 (hu) | Indolszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| ES2167608T3 (es) | Composicion basada en monoxido de nitrogeno como medicamento. | |
| NO20040096L (no) | Taxol-forbedringsforbindelser | |
| DK0934309T3 (da) | Nye pyridylalkansyreamider som cytostatiske og immunosuppressive midler | |
| DE69713151D1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
| EP1389616A4 (en) | NEW BENZYL PIPERIDINE COMPOUND | |
| AR030021A1 (es) | COMPUESTO DE UNA PIRIMIDINONAS SUSTITUIDA,COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE Y EL USO DE DICHO COMPUESTO Y DE DICHA COMPOSICIoN EN LA FABRICACIoN DE MEDICAMENTOS uTILES PARA LA INHIBICION SELECTIVA DE LA CASCADA DE COAGULACIoN | |
| WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
| YU40002A (sh) | Antipikornavirusna jedinjenja i kompozicije, njihove farmaceutske upotrebe, i materijali za njihove sinteze | |
| DE50113345D1 (de) | Arginin-mimetika als faktor xa-inhibitoren | |
| HUP0102009A1 (hu) | Szintetikus poliszacharidok, előállítási eljárásuk, valamint az ezeket tartalmazó gyógyszerkompozíciók | |
| ATE206926T1 (de) | Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FH91 | Appointment of a representative |
Free format text: FORMER REPRESENTATIVE(S): DR. PALAGYI TIVADAR, DANUBIA SZABADALMI ES VEDJEGY IRODA KFT., HU Representative=s name: IFJ. SZENTPETERI ADAM, S.B.G. & K. SZABADALMI , HU |
|
| FH92 | Termination of representative |
Representative=s name: DR. PALAGYI TIVADAR, DANUBIA SZABADALMI ES VED, HU |
|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |